Burundi vs Pakistan: HIV/AIDS deaths averted by antiretroviral therapy
Burundi
4,624 deaths
in 2024
Pakistan
4,811 deaths
in 2024
Burundi rank
39th
Pakistan rank
38th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Burundi
- Pakistan
How they compare
Pakistan currently reports 4,811 deaths against 4,624 deaths in Burundi, a difference of 187 deaths.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Pakistan ahead.
Burundi ranks 39th and Pakistan ranks 38th of 157 countries.
Burundi has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Burundi | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 1,207 deaths | 49.67 deaths | 1,158 deaths | Burundi |
| 2010s | 4,004 deaths | 854.17 deaths | 3,150 deaths | Burundi |
| 2020s | 4,704 deaths | 3,244 deaths | 1,460 deaths | Burundi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Burundi or Pakistan?
- Pakistan, at 4,811 deaths against 4,624 deaths in Burundi as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Burundi and Pakistan?
- 187 deaths, with Pakistan ahead.
- How many years of comparable data are there for Burundi and Pakistan?
- 35 years are reported by both, from 1990 to 2024.
- How do Burundi and Pakistan rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Burundi ranks 39th and Pakistan ranks 38th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.